Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial-Reference-Cited by-同舟云学术

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Published:2021-03 Issue:10279 Volume:397 Page:1063-1074
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Butler Christopher C,Dorward Jienchi,Yu Ly-Mee,Gbinigie Oghenekome,Hayward Gail,Saville Benjamin R,Van Hecke Oliver,Berry Nick,Detry Michelle,Saunders Christina,Fitzgerald Mark,Harris Victoria,Patel Mahendra G,de Lusignan Simon,Ogburn Emma,Evans Philip H,Thomas Nicholas PB,Hobbs FD Richard

Funder

NIHR

Wellcome Trust

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Therapy for early COVID-19: a critical need;Kim;JAMA,2020

2. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication;Touret;Sci Rep,2020

3. Azithromycin in viral infections;Oliver;Rev Med Virol,2020

4. Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory epithelial cells;Poschet;bioRxiv,2020

5. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade;Coutard;Antiviral Res,2020

Cited by 241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes;Journal of Infection;2024-10

2. Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial;The Lancet Infectious Diseases;2024-09

3. Novel quinazoline sulfonamide-based scaffolds modulate methicillin-resistant Staphylococcus aureus (MRSA) pneumonia in immunodeficient irradiated model: Regulatory role of TGF-β;Bioorganic Chemistry;2024-09

4. Epidemiology and Impact of Anti-Pneumococcal Vaccination and COVID-19 on Resistance of Streptococcus pneumoniae Causing Invasive Disease in Piedmont, Italy;Antibiotics;2024-08-06

5. Nasal sprays and behavioural interventions compared with usual care for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial;The Lancet Respiratory Medicine;2024-08